I’d be happy with FDA approval in next five trading days including a decent contract then a solid Compass deal for ilumen by end of month.
If this board cannot sign up revenue under the current conditions created by COVID there is something seriously wrong that we don’t know about.
Wasnt it April (and earlier) that they were in discussions with Compass, what are we now, three months down the track and what has come of it? More short paragraphs in announcements tempting investors to believe that things are progressing on the company front with these negotiations...
I thought all the bull**** left with the old board, next few weeks will shows us what Claude and Co and Medibio are made of in my opinion.
I’d be happy with FDA approval in next five trading days...
Add TRI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.4¢ |
Change
-0.001(2.86%) |
Mkt cap ! $11.50M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 3.6¢ | 3.3¢ | $43.51K | 1.270M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15500 | 3.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.6¢ | 232405 | 1 |
View Market Depth
| Last trade - 15.17pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
3.5¢ |
Change
-0.001 ( 2.94 %) |
||||
| Open | High | Low | Volume | ||
| 3.5¢ | 3.5¢ | 3.5¢ | 137000 | ||
| Last updated 15.00pm 07/05/2024 ? | |||||
| TRI (ASX) Chart |